moclobemide has been researched along with Stroke in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We randomised 90 acute stroke patients with aphasia to either 600 mg moclobemide or placebo daily for 6 months, within 3 weeks of the onset of stroke." | 9.11 | Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. ( Hellblom, A; Kahan, T; Laska, AC; Murray, V; von Arbin, M, 2005) |
| "We randomised 90 acute stroke patients with aphasia to either 600 mg moclobemide or placebo daily for 6 months, within 3 weeks of the onset of stroke." | 5.11 | Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study. ( Hellblom, A; Kahan, T; Laska, AC; Murray, V; von Arbin, M, 2005) |
| "To compare standardized and functional aphasia tests in patients after acute stroke." | 2.73 | Clinical and prognostic properties of standardized and functional aphasia assessments. ( Bartfai, A; Hellblom, A; Kahan, T; Laska, AC; Murray, V, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laska, AC | 2 |
| von Arbin, M | 1 |
| Kahan, T | 2 |
| Hellblom, A | 2 |
| Murray, V | 2 |
| Bartfai, A | 1 |
2 trials available for moclobemide and Stroke
| Article | Year |
|---|---|
Long-term antidepressant treatment with moclobemide for aphasia in acute stroke patients: a randomised, double-blind, placebo-controlled study.
Topics: Aged; Aged, 80 and over; Aphasia; Double-Blind Method; Drug Administration Schedule; Female; Follow- | 2005 |
Clinical and prognostic properties of standardized and functional aphasia assessments.
Topics: Antidepressive Agents; Aphasia; Double-Blind Method; Follow-Up Studies; Humans; Moclobemide; Monoami | 2007 |